Eris Lifesciences Limited — Others, 19-02-2025: Giving guarantees/indemnity/ becoming a surety for third party

Eris Lifesciences has announced a board meeting to discuss a corporate guarantee issued for its wholly owned subsidiary, Eris Therapeutics Limited (ETL), securing a credit facility of ₹150 crore from the State Bank of India. This guarantee will be recorded as a contingent liability in the standalone financials of Eris Lifesciences. The decision underscores the company's support for ETL's financial needs. Investors may view this as a supportive move, reflecting confidence in ETL's operations but should remain aware of the potential risks associated with contingent liabilities.